Albert S. DeNittis - Concepedia

Author

Albert S. DeNittis

Also Known As

A DeNittis, A S DeNittis, A. DeNittis, A. S. DeNittis, A.S. DeNittis, A.S. Denittis, AL DENITTIS, Albert DeNittis, Albert Denittis, Albert S DeNittis

292

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

NRG Oncology University of Pennsylvania Lankenau Medical Center Lankenau Institute for Medical Research Main Line Health

About

Albert S. DeNittis is an author at NRG Oncology specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Health Sciences	5	5	331
3	Arts	1	1	97
4	Social Sciences	1	1	35
5	Communication	1	1	97

Albert S. DeNittis

Publications

Citations

H-Index

Page 1

	Year	Citations
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Journal of Clinical Oncology	2014	1.1K
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Annals of Oncology Breast OncologyOverall SurvivalMedicinePathologyGermline Pathogenic Variants	2022	404
Prediction of Survival by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial Mitchell Machtay, Fenghai Duan, Barry A. Siegel, Journal of Clinical Oncology	2013	172
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer Theodore S. Hong, Jennifer Moughan, Michael Garofalo, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineRadionuclide TherapyPhase 2Clinical Radiation Oncology	2015	116
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial Ethan Basch, Stephanie L. Pugh, Amylou C. Dueck, International Journal of Radiation OncologyBiologyPhysics Adverse EventsOncologyAdverse EventClinical EndpointPatient Safety	2017	115
Patient Initiation of Complementary and Alternative Medical Therapies (CAM) Following Cancer Diagnosis Neha Vapiwala, Rosemarie Mick, Margaret K. Hampshire, The Cancer Journal	2006	113
A multi-institutional study of Internet utilization by radiation oncology patients James M. Metz, Pamela Devine, Albert S. DeNittis, International Journal of Radiation OncologyBiologyPhysics Social MediaTelehealthArtsTechnological AddictionInternet Utilization	2003	97
Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Peiyong Li, Hongming Zhuang, P. David Mozley, Clinical Nuclear Medicine	2001	79
Pretreatment<sup>18</sup>F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235 Nitin Ohri, Fenghai Duan, Bradley S. Snyder, Journal of Nuclear Medicine	2016	78
Internet use by patients with prostate cancer undergoing radiotherapy Ryan P. Smith, P. Devine, Heather Jones, Urology UrologyMedicineInternet Addiction DisorderProblematic Smartphone UseTelehealth	2003	75

Page 1